URO-1 develops products for office procedures in urology. Its first product, the Repris™ Bladder Injection System, is designed after a protocol shown to reduce complications following onabotulinumtoxinA treatment for overactive bladder (OAB). Results from an ongoing study indicate a significant reduction in post procedure complications and improved patient tolerance.
The Repris product features the Re4m™ memory cannula/needle and the Rely™ self-metering syringe. The former enables the user to reach lateral areas of the bladder wall with minimal to no manipulation of the cystoscope. The latter allows delivery of a precise dose of the drug without looking away from the target to visually confirm such delivery.
The other products in the company’s pipeline are in the final stages of development.